Radafaxine

DRUG3 trials

Sponsors

GlaxoSmithKline

Conditions

Depressive Disorder, MajorMajor Depressive Disorder (MDD)

Phase 2

An 8 Week Depression Study In Adults Diagnosed With Major Depressive Disorder

CompletedNCT00057239

GlaxoSmithKlineMajor Depressive Disorder (MDD)

Start: 2003-03-31End: 2004-05-31Target: 546Updated: 2010-10-04

An 8 Week Study Of Adults Diagnosed With Major Depressive Disorder

CompletedNCT00057226

GlaxoSmithKlineDepressive Disorder, Major

Start: 2003-03-31End: 2004-04-30Updated: 2015-04-16

An 8 Week Study Of Depression In Adults Diagnosed With Major Depressive Disorder

CompletedNCT00057213

GlaxoSmithKlineDepressive Disorder, Major

Start: 2003-03-31End: 2007-04-30Updated: 2015-04-16